We’re excited to share that NBE-Therapeutics will be heading to Boston for the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, happening from October 22nd to 26th, 2025. This event is a key gathering for the oncology community, bringing together scientists, clinicians, and industry experts to dive into the latest advancements in cancer research and drug development.
It’s a fantastic chance for us to stay on top of cutting-edge discoveries, connect with others in the field, and exchange ideas about the future of cancer therapeutics. We’re looking forward to being part of the conversations that drive innovation and progress.
If you’re attending, let’s connect in Boston!
We are delighted to share that NBE-Therapeutics will be attending PEGS Europe 2025, scheduled to take place from the 11th to the 13th of November in Lisbon, Portugal. Recognized as a premier gathering for the protein and antibody engineering community, this event brings together leading experts, innovators, and thought leaders to explore the forefront of biologics and biotherapeutics development.
PEGS Europe offers an unparalleled opportunity for us to immerse ourselves in the latest scientific advancements, exchange ideas with industry pioneers, and foster meaningful collaborations. We are eager to contribute to the vibrant discussions and gain fresh perspectives that will help drive innovation in our field.
We look forward to engaging with the community and connecting with you in Lisbon!
We are excited to announce that NBE-Therapeutics will be attending the ESMO Congress 2025 in Berlin, taking place from the 17th to the 21st of October. This highly influential global oncology platform brings together clinicians, researchers, patient advocates, journalists, and healthcare industry representatives from all over the world.
This presents a fantastic opportunity for us to connect, learn, and exchange valuable insights regarding the most recent advancements in our field. We are highly enthusiastic about actively participating in meaningful exchanges and engaging in insightful discussions throughout the event.
We are excited to announce that NBE-Therapeutics will be attending the WORLD ADC San Diego 2025, taking place from the 3rd to the 6th of November in San Diego. This premier global platform for antibody-drug conjugates (ADCs) brings together leading scientists, researchers, clinicians, and industry experts from around the world.
This event offers a unique opportunity for us to connect, collaborate, and exchange valuable insights on the latest advancements in ADC research and development. We are eager to actively participate in meaningful discussions, share knowledge, and engage with the vibrant ADC community throughout the conference.
We look forward to seeing you there!